PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 76 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $216,000 | -19.7% | 56,789 | +7.4% | 0.00% | – |
| Q4 2019 | $269,000 | -7.2% | 52,866 | -4.4% | 0.00% | – |
| Q3 2019 | $290,000 | -15.0% | 55,284 | 0.0% | 0.00% | – |
| Q2 2019 | $341,000 | +26.3% | 55,284 | -5.0% | 0.00% | – |
| Q1 2019 | $270,000 | +18.9% | 58,185 | +7.5% | 0.00% | – |
| Q4 2018 | $227,000 | -36.8% | 54,147 | -5.5% | 0.00% | – |
| Q3 2018 | $359,000 | -33.5% | 57,272 | -14.7% | 0.00% | -100.0% |
| Q2 2018 | $540,000 | +13.4% | 67,144 | +5.1% | 0.00% | 0.0% |
| Q1 2018 | $476,000 | +28.6% | 63,864 | +2.4% | 0.00% | – |
| Q4 2017 | $370,000 | -17.8% | 62,380 | +2.2% | 0.00% | -100.0% |
| Q3 2017 | $450,000 | +9.2% | 61,054 | +0.7% | 0.00% | 0.0% |
| Q2 2017 | $412,000 | -25.8% | 60,600 | +3.2% | 0.00% | 0.0% |
| Q1 2017 | $555,000 | +85.6% | 58,732 | +69.1% | 0.00% | – |
| Q4 2016 | $299,000 | -10.5% | 34,723 | -34.2% | 0.00% | – |
| Q3 2016 | $334,000 | +51.1% | 52,776 | +0.4% | 0.00% | – |
| Q2 2016 | $221,000 | +9.4% | 52,567 | +10.8% | 0.00% | – |
| Q1 2016 | $202,000 | -30.1% | 47,449 | +0.6% | 0.00% | – |
| Q4 2015 | $289,000 | +8.2% | 47,172 | +1.1% | 0.00% | – |
| Q3 2015 | $267,000 | -22.4% | 46,662 | +1.2% | 0.00% | – |
| Q2 2015 | $344,000 | +23.7% | 46,116 | -0.7% | 0.00% | – |
| Q1 2015 | $278,000 | -19.0% | 46,453 | +2.2% | 0.00% | – |
| Q4 2014 | $343,000 | +51.1% | 45,468 | +4.0% | 0.00% | – |
| Q3 2014 | $227,000 | +18.2% | 43,713 | -1.8% | 0.00% | – |
| Q2 2014 | $192,000 | +2.1% | 44,504 | -3.2% | 0.00% | – |
| Q1 2014 | $188,000 | -24.2% | 45,966 | -1.1% | 0.00% | – |
| Q4 2013 | $248,000 | +13.8% | 46,476 | +7.2% | 0.00% | – |
| Q3 2013 | $218,000 | +13.5% | 43,350 | +1.1% | 0.00% | – |
| Q2 2013 | $192,000 | – | 42,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|